Health System

Oncology pharmacy practitioners highlight challenges amid the pandemic, such as limited access to personal protective equipment and essential medications.

Though antibiotics are crucial, concern about overuse in hospitals and inappropriate prescribing practices fuels debate about the complex relationship between antibiotic use and antimicrobial resistance.

Officials with the FDA have approved imipenem, cilastatin, and relebactam (Recarbrio, Merck) for the treatment of adults with hospital-acquired and ventilator-associated bacterial pneumonia. 

An analysis found that US patients with COVID-19 are experiencing longer hospital stays and higher rates of ICU admissions than patients in China.

The findings, which were presented virtually in the 2020 ASCO Virtual Scientific Program, included the association between treatment with hydroxychloroquine plus azithromycin and increased risk of death.

The US Department of Health & Human Services has left it up to state health departments to decide how to distribute remdesivir to hospitals.

Today, the American Society of Health-System Pharmacists (ASHP) sent a letter to Vice President Mike Pence to urge the transparent and orderly allocation of remdesivir among hospitals

A case report from NYU Langone Health assessed the use of both urgent and non-urgent telemedicine visits.

Here's the roundup of the latest coronavirus-related news.

The study examined the effects of unprotected, prolonged patient contact, along with certain exposures, on the risk of health care providers becoming infected with COVID-19.

Here's a roundup of the latest coronavirus-related news.

Merck has announced the US launch of trastuzumab-dttb (Ontruzant), a biosimilar to trastuzumab (Herceptin), in both 150-mg single-dose vials and 420-mg multiple-dose vials.

In part 2 of our video interview, Robert Brunault, PharmD, a clinical pharmacy specialist in hematology and oncology at Rhode Island Hospital and the Lifespan Cancer Institute, discussed drug shortages, FDA emergency use authorizations, and the biggest concerns for pharmacists.

Here's a roundup of the latest coronavirus-related news.

The letter asks the vice president to increase manufacturing of these medications based on current projections of critical care patient volume.

What does it mean for patients?

Pharmacists are positioned to play a key role in preventing or catching errors that can occur at the various stages of the drug-use process: prescribing, dispensing, and administration.

The FDA’s public- and private-sector partnership will expedite thousands of units of plasma to patients with severe COVID-19 symptoms, the news release said.

Facing disruptions in medical mask supplies, some hospital staff are re-using masks and using alternative types, according to a new survey.

Here's a roundup of the latest coronavirus-related news.

Officials with the FDA have approved durvalumab (Imfinzi) for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC), in combination with standard-of-care (SoC) chemotherapies, in adult patients.

Here’s a roundup of the latest coronavirus-related news from this week. 

Health care providers should look out for more than just respiratory diagnoses in patients when it comes to influenza-associated complications, according to a recent study. 

Tissue plasminogen activator, which is used to treat blood clots, may help severely ill patients with COVID-19 who are in respiratory failure, according to a new paper.

Officials with the FDA have approved a 420-mg multi-dose of trastuzumab-bttb (Ontruzant, Samsung Bioepis), a biosimilar referencing trastuzumab (Herceptin).